Forensic Analysis · Utilities · as of Jun 27, 2026
TRANSALTA CORP (TAC)
A forensic read on TRANSALTA CORP built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Clean
Earnings quality
2
Forensic signals
-11.6%
ROE
$4.1B
Market cap
1.44%
Dividend yield
TRANSALTA CORP earns a B (Sound & dependable) forensic quality grade. 2 forensic signals were flagged in its latest SEC filings, led by receivables vs revenue.
What the filings flag
106d DSOReceivables vs revenue. Days sales outstanding moved from 98 to 106 days FY2024→FY2025 (receivables -9% vs revenue -15%). Receivables are creeping up relative to sales — watch the trend.
9%Return on invested capital. Return on invested capital is 9% and slipping from 34% — around its ~6% cost of capital, so growth is roughly value-neutral — watch the trend.
Key fundamentals
Net Margin-6.6%
Latest Revenue$1.70B
Return on Equity-10.8%
Revenue Growth YoY-15.5%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on TRANSALTA CORP:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about TAC's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown
🔒Peer comparison + filing-change monitoring & alerts
No credit card · informational only, not investment advice · see the track record
← Browse all forensic stock analyses
Data from SEC EDGAR public filings · metrics as of Jun 27, 2026. Forensic signals flag probability, not certainty.